Tuesday, June 19, 2018
BTI Biotechnology Institute is the pioneering company leading the market in the development of tissue regeneration techniques through the therapeutic use of plasma rich in growth factors.
BTI Biotechnology Institute is the pioneering company leading the market in the development of tissue regeneration techniques through the therapeutic use of plasma rich in growth factors.
Endoret® (PRGF®) technology, which enables us to obtain a series of 100% autologous biomaterials with a high regenerative and healing potential, has demonstrated a high level of efficacy in dental extraction procedures, thus making it possible to preserve the oral tissues and minimise alveolar atrophy, with no side effects for the patient.
The specific kit for the application of this technology in the post-extraction socket, containing all the accessories necessary to obtain the biomaterials, is called KMU16.
